Phenotypic consequences of red–white colony type variation in Mycobacterium avium

References

1. Belisle J. T., Brennan P. J. 1994; Molecular basis of colony morphology in Mycobacterium avium . Res Microbiol 145:237–242 [CrossRef]
   [Google Scholar]
2. Belisle J. T., Klaczkiewicz K., Inamine J. M, Brennan P. J., Jacobs W. R. Jr 1993; Rough morphological variants of Mycobacterium avium : characterization of genomic deletions resulting in the loss of glycopeptidolipid expression. J Biol Chem 268:10517–10523
   [Google Scholar]
3. Bermudez L. E., Petrofsky M., Kolonoski P., Young L. S. 1991; An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract. J Infect Dis 165:75–79
   [Google Scholar]
4. Bermudez L. E., Parker A., Goodman J. 1997; Growth within macrophages increases the efficiency of Mycobacterium avium to invade human macrophages by a complement receptor-independent pathway. Infect Immun 65:1916–1922
   [Google Scholar]
5. Bermudez L. E., Kolonoski P., Wu M., Aralar P. A., Inderlied C. B., Young L. S. 1999; Mefloquine is active in vitro and in vivo against the Mycobacterium avium complex. Antimicrob Agents Chemother 43:1870–1874
   [Google Scholar]
6. Cangelosi G. A., Palermo C. O., Laurent J.-P., Hamlin A. M., Brabant W. H. 1999; Colony morphotypes on Congo red agar segregate along species and drug susceptibility lines in the Mycobacterium avium-intracellulare complex. Microbiology 145:1317–1324 [CrossRef]
   [Google Scholar]
7. Heifets L. 1996; Susceptibility testing of Mycobacterium avium complex isolates. Antimicrob Agents Chemother 40:1759–1767
   [Google Scholar]
8. Hsu N., Young L., Bermudez L. E. 1995; Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with Mycobacterium avium complex. Infect Immun 63:528–534
   [Google Scholar]
9. Inderlied C. B., Nash K. A. 1996; Microbiology and in vitro susceptibility testing. In Mycobacterium avium Complex Infection: Progress in Research and Treatment pp 100–140 Edited by Korvick J. A., Benson C. A. New York: Marcel Dekker;
   [Google Scholar]
10. Inderlied C. B., Kemper C. A., Bermudez L. E. M. 1993; The Mycobacterium avium complex. Clin Microbiol Rev 6:266–310
    [Google Scholar]
11. Jarlier V., Nikaido H. 1994; Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123:11–18 [CrossRef]
    [Google Scholar]
12. Martinez A., Torello S., Kolter R. 1999; Sliding motility in mycobacteria. J Bacteriol 181:7331–7338
    [Google Scholar]
13. Mdluli K., Swanson J., Fischer E., Lee R. E., Barry C. E. 1998; Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 27:1223–1233 [CrossRef]
    [Google Scholar]
14. Peloquin C. A. 1997; Mycobacterium avium complex infection: pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes. Clin Pharmacokinet 32:52–144
    [Google Scholar]
15. Portillo-Gomez L., Nair J., Rouse D. A., Morris S. L. 1995; The absence of genetic markers for streptomycin and rifampicin resistance in Mycobacterium avium complex strains. J Antimicrob Chemother 36:1049–1053 [CrossRef]
    [Google Scholar]
16. Prinzis S., Rivoire B., Brennan P. J. 1994; Search for the molecular basis of morphological variation in Mycobacterium avium . Infect Immun 62:1946–1951
    [Google Scholar]
17. Sison J. P., Yao Y., Kemper C. A., Hamilton J. R., Brummer E., Stevens D. A., Deresinski S. C. 1996; Treatment of Mycobacterium avium complex infection: do the results of the in vitro susceptibility tests predict therapeutic outcome in humans?. J Infect Dis 173:677–683 [CrossRef]
    [Google Scholar]
18. Woodley C. L., David H. L. 1976; Effect of temperature on the rate of transparent to opaque colony type transition in Mycobacterium avium . Antimicrob Agents Chemother 9:113–119 [CrossRef]
    [Google Scholar]